相似文献
1
Sepsis biomarkers: a review.
Crit Care. 2010;14(1):R15. doi: 10.1186/cc8872. Epub 2010 Feb 9.
2
The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
Surg Infect (Larchmt). 2013 Dec;14(6):489-511. doi: 10.1089/sur.2012.028. Epub 2013 Nov 25.
3
Early increases in serum FGF21 levels predict mortality of septic patients.
Cytokine. 2018 Nov;111:428-433. doi: 10.1016/j.cyto.2018.05.020. Epub 2018 Jun 1.
4
Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study.
PLoS One. 2018 Oct 17;13(10):e0205924. doi: 10.1371/journal.pone.0205924. eCollection 2018.
5
Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkers of infection or sepsis in patients presenting to emergency department.
Clin Chem Lab Med. 2014 Oct;52(10):1465-72. doi: 10.1515/cclm-2014-0210.
6
The Use of Biomarkers in Sepsis: A Systematic Review.
Curr Pharm Biotechnol. 2017;18(6):499-507. doi: 10.2174/1389201018666170601080111.
7
Biomarkers of sepsis: time for a reappraisal.
Crit Care. 2020 Jun 5;24(1):287. doi: 10.1186/s13054-020-02993-5.
8
Interleukin-10 and interleukin-1 receptor antagonist distinguish between patients with sepsis and the systemic inflammatory response syndrome (SIRS).
Cytokine. 2019 Aug;120:227-233. doi: 10.1016/j.cyto.2019.05.015. Epub 2019 May 21.
9
Lipidomic profile and candidate biomarkers in septic patients.
Lipids Health Dis. 2020 Apr 13;19(1):68. doi: 10.1186/s12944-020-01246-2.
10
Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients.
J Int Med Res. 2014 Aug;42(4):1050-9. doi: 10.1177/0300060514528483. Epub 2014 May 14.
引用本文的文献
1
Sepsis detection in hematologic and solid tumor malignancies using quantitative inflammatory biomarker differences in a prospective single center study.
Sci Rep. 2025 Aug 28;15(1):31701. doi: 10.1038/s41598-025-15784-1.
2
Co-Evaluation of Lactate, Base Excess, and Albumin as Predictors of Mortality in Sepsis by Excluding the Factors That Affect Their Levels: An Observational Study.
Biomedicines. 2025 Aug 8;13(8):1932. doi: 10.3390/biomedicines13081932.
3
Lower Initial Insulin-like Growth Factor-Binding Protein-3 Concentrations May Reflect Immune Suppression and Predict Increased Risk of Sepsis-Related Mortality.
Int J Mol Sci. 2025 Jul 8;26(14):6549. doi: 10.3390/ijms26146549.
4
Biomarkers to guide sepsis management.
Ann Intensive Care. 2025 Jul 21;15(1):103. doi: 10.1186/s13613-025-01524-1.
5
Association of heparin-binding protein with risk of in-hospital heart failure in patients with acute coronary syndrome.
Am J Transl Res. 2025 Jun 15;17(6):4237-4246. doi: 10.62347/LQLD9274. eCollection 2025.
6
Point of care sepsis diagnosis: Exploring microfluidic techniques for sample preparation, biomarker isolation, and detection.
Biomicrofluidics. 2025 Jul 1;19(4):041502. doi: 10.1063/5.0248096. eCollection 2025 Jul.
7
L-shape association between serum chloride and 365-day mortality in critically ill patients with sepsis based on the MIMIC-IV database.
Sci Rep. 2025 Jul 1;15(1):20391. doi: 10.1038/s41598-025-08630-x.
8
A Knowledge-Enhanced Platform (MetaSepsisKnowHub) for Retrieval Augmented Generation-Based Sepsis Heterogeneity and Personalized Management: Development Study.
J Med Internet Res. 2025 Jun 6;27:e67201. doi: 10.2196/67201.
9
Intensive care infection score: ICIS discriminates between infected and uninfected critically ill patients in routine intensive care unit practice.
Intensive Care Med Exp. 2025 Jun 5;13(1):58. doi: 10.1186/s40635-025-00767-3.
10
Battle of the Biomarkers of Systemic Inflammation.
Biology (Basel). 2025 Apr 18;14(4):438. doi: 10.3390/biology14040438.
本文引用的文献
1
Biomarkers of sepsis.
Crit Care Med. 2009 Jul;37(7):2290-8. doi: 10.1097/CCM.0b013e3181a02afc.
2
Serial cytokine levels in patients with severe sepsis.
Inflamm Res. 2009 Jul;58(7):385-93. doi: 10.1007/s00011-009-0003-0. Epub 2009 Mar 5.
3
Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS.
J Pharmacol Toxicol Methods. 2009 May-Jun;59(3):171-80. doi: 10.1016/j.vascn.2009.02.004. Epub 2009 Feb 28.
4
Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit.
Shock. 2009 Jun;31(6):586-91. doi: 10.1097/SHK.0b013e31819716fa.
5
Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster.
J Crit Care. 2008 Dec;23(4):455-60. doi: 10.1016/j.jcrc.2007.08.003. Epub 2007 Dec 11.
6
A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis.
Crit Care Med. 2009 Jan;37(1):96-104. doi: 10.1097/CCM.0b013e318192fd9d.
7
Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
Arch Intern Med. 2008 Oct 13;168(18):2000-7; discussion 2007-8. doi: 10.1001/archinte.168.18.2000.
8
Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis.
Am J Perinatol. 2008 Nov;25(10):629-36. doi: 10.1055/s-0028-1090585. Epub 2008 Oct 10.
9
B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients.
Crit Care Med. 2008 Nov;36(11):3030-7. doi: 10.1097/CCM.0b013e31818b9153.
10
Serum levels of osteopontin are increased in SIRS and sepsis.
Intensive Care Med. 2008 Dec;34(12):2176-84. doi: 10.1007/s00134-008-1268-4. Epub 2008 Sep 20.
Zotero 插件